A particular form of epilepsy only affects children, the syndrom "Lennox-Gastaud". At the American hospital in Reims, a new drug, Lamotrigine is in the testing phase. A child’s hospital views during care and interview with Professor Jacques MOTTE, the child’s neurology, explains: "From the moment these seizures appear, children regress, no longer learn (...) and so far no treatment was effective in this epilepsy...".
Accessible rights for all uses, in the whole world, in accordance with our T&Cs.
Digital Publication : use for editorial publications - to inform the general public or illustrate the news - for digital broadcast on services, valid for 5 years.
Corporate/Brand content : use for the presentation and promotion of an image, brand, history and values of the Contracting Partner company - or, where applicable, the Beneficiary - for digital broadcast on its services and/or for Events, valid for 1 year.
Cultural Licence : use for cultural purposes and restricted to members of the cultural network. Digital publication for a term of 5 (years) and Events for a term of 1 (one) year from the order payment date.
Reference:RE00001233775
Credits:Journalist : Lagun Bouchet, Luc-Photo Journalist : Boudet, Thierry-Film Editor : Chauvelot, Marc-Participant : Motte, Jacques